Live from the NIH registry
Studies recruiting near Fontana right now
Top 25 of 958 recruiting studies, sorted by proximity — each links to its official registry page
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
City of Hope National Medical Center — Duarte, California (29.7 mi)
· Sponsor: Relay Therapeutics, Inc.
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Lymphoma, B-Cell, Lymphoma, Non-Hodgkin (NHL)
Phase 1
Interventional 106 participants sought
City of Hope — Duarte, California (29.7 mi)
· Sponsor: Umoja Biopharma
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
City of Hope — Duarte, California (29.7 mi)
· Sponsor: Nurix Therapeutics, Inc.
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Phase 1
Interventional 36 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: PeproMene Bio, Inc.
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Velocity Clinical Research - San Bernardino — San Bernardino, California (9.8 mi)
· Sponsor: Crystalys Therapeutics
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Retina Consultants of Southern CA — Redlands, California (16.1 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
Kaiser Permanente-Ontario — Ontario, California (11.2 mi)
· Sponsor: National Cancer Institute (NCI)
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Brain Cancer, Breast Cancer
N/A
Observational 7,000 participants sought
City of Hope — Duarte, California (29.7 mi)
· Sponsor: Adela, Inc
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Phase 1, Phase 2
Interventional 83 participants sought
Research Site — Duarte, California (29.7 mi)
· Sponsor: AstraZeneca
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
Type 2 Diabetes
Phase 2
Interventional 60 participants sought
Catalina Research Institute, LLC — Montclair, California (13.2 mi)
· Sponsor: Biomea Fusion Inc.
Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)
Cesarean Section Complications, Cesarean Section; Infection
N/A
Interventional 400 participants sought
Loma Linda University — Loma Linda, California (11.9 mi)
· Sponsor: Loma Linda University
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 2
Interventional 35 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.
Dental Pain and Sensation Disorder, Pain, Postoperative
Phase 4
Interventional 98 participants sought
Loma Linda University Health — Loma Linda, California (11.9 mi)
· Sponsor: Loma Linda University
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
Thyroid Gland Carcinoma
N/A
Interventional 1,450 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Unresectable, Locally Advanced
Phase 1, Phase 2
Interventional 170 participants sought
City of Hope — Duarte, California (29.7 mi)
· Sponsor: Recursion Pharmaceuticals Inc.
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Hematologic Malignancies
Phase 1, Phase 2
Interventional 160 participants sought
City of Hope National Medical Center — Duarte, California (29.7 mi)
· Sponsor: Sellas Life Sciences Group
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 140 participants sought
Prospective Research Innovations — Rancho Cucamonga, California (7.7 mi)
· Sponsor: Eli Lilly and Company
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia
Phase 1
Interventional 27 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous Gamma-Delta T-Cell Lymphoma
Phase 1, Phase 2
Interventional 200 participants sought
Dren Investigational Site — Duarte, California (29.7 mi)
· Sponsor: Dren Bio
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Schizophrenia
Phase 3
Interventional 690 participants sought
Reviva site — Riverside, California (10.6 mi)
· Sponsor: Reviva Pharmaceuticals
Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Glioblastoma
N/A
Observational 160 participants sought
City of Hope Medical Center — Duarte, California (29.7 mi)
· Sponsor: City of Hope Medical Center
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Loma Linda University Medical Center — Loma Linda, California (11.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Empire Clinical Research — Pomona, California (17.0 mi)
· Sponsor: Incyte Corporation
Metabolic Cost of Walking With Passive vs. Powered Prosthetic Knees Among Persons With Limb Loss
Transfemoral Amputation
N/A
Interventional 12 participants sought
Loma Linda University — Loma Linda, California (11.9 mi)
· Sponsor: Loma Linda University
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 3
Interventional 380 participants sought
VA Loma Linda Healthcare System /ID# 261015 — Loma Linda, California (11.9 mi)
· Sponsor: AbbVie